Questions to Ask Your Fertility Doctor After Testing
Fertility test results are information—not a complete diagnosis or a prediction that pregnancy will or will not happen. After testing, ask your fertility doctor what each result means for you, what it does not show, and how it changes your next steps. The Centers for Disease Control and Prevention (CDC) reports that about 1 in 5 U.S. women ages 15–49 with no prior births are unable to get pregnant after one year of trying; because fertility evaluation can involve both partners and several possible causes, a useful follow-up visit should cover the findings, their limits, treatment choices, timing, risks, costs, and emotional support.
Fertility test results: what they can—and cannot—tell you
A fertility evaluation is a clinical assessment of reproductive factors that may affect the chance of pregnancy. The American Society for Reproductive Medicine (ASRM) describes infertility evaluation as a systematic process guided by medical history, age, how long you have been trying, and individual risk factors. Testing often assesses ovulation, reproductive anatomy, ovarian reserve, and semen—but no single result reliably answers every question about whether or when pregnancy will occur.
Start by asking your doctor to explain the results in plain language and connect them to your personal situation. A result outside a laboratory’s reference range is not automatically a diagnosis, while a result within range does not guarantee fertility. Ask which findings are clinically important, whether results need repeating, and what additional information would change the care plan.
What is the most likely explanation for our results?
Ask whether the results suggest a specific factor, several contributing factors, or unexplained infertility. The World Health Organization defines infertility as a disease of the male or female reproductive system, characterized by failure to achieve pregnancy after 12 months or more of regular unprotected sexual intercourse. Depending on age and medical history, a clinician may recommend evaluation sooner than 12 months. Request a clear distinction between a confirmed diagnosis, a possible explanation, and an inconclusive finding.
What can each test tell us—and what can it not tell us?
Ask your doctor to explain the purpose and limitations of each test. For example, ovarian-reserve measures can help estimate response to ovarian stimulation, but ASRM cautions that they are poor independent predictors of reproductive potential apart from age. A semen analysis describes characteristics of a sample, not a definitive verdict on whether natural conception is possible. Understanding these limits can prevent a single number from being treated as a complete forecast.
Questions about ovulation and ovarian-reserve findings
Once you understand the overall interpretation, ask how specific findings relate to the reproductive processes they assess. Ovulation testing and ovarian-reserve testing answer different questions, so they should not be treated as interchangeable measures of fertility.
Are I ovulating regularly, and how was that assessed?
Ovulation is the release of an egg from an ovary. Ask whether your cycle history or test results suggest regular ovulation, and whether the timing of bloodwork was appropriate for your cycle. If cycles are irregular or ovulation appears absent, ask about potential causes and whether further evaluation is appropriate. The next step depends on the pattern of results and your medical history rather than on one test alone.
What do my AMH, FSH, and antral follicle count mean together?
Anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), and antral follicle count are commonly used to assess ovarian reserve—the quantity-related aspect of the remaining egg supply and, in treatment, likely response to stimulation. Ask how your age, the specific laboratory, medication use, and test timing affect interpretation. ASRM emphasizes that ovarian-reserve testing should not be used as a stand-alone fertility test or as a direct measure of egg quality. Ask what the results mean for treatment planning, not just whether they are labeled “normal” or “abnormal.”
Should we investigate why my cycles are irregular or absent?
Irregular or absent periods can be a clue that ovulation is not occurring predictably, but the cause varies. Ask whether your history and results suggest a hormonal, metabolic, medication-related, or other factor, and what evaluation is warranted. Also ask whether addressing an underlying condition could improve general health as well as the fertility plan.
Questions about reproductive anatomy and sperm testing
Fertility evaluation is not limited to ovarian or hormone results. Depending on your history, clinicians may assess the uterus and fallopian tubes and recommend semen testing. Because infertility can involve either partner or both, asking how the tests fit together can help avoid an incomplete assessment.
Are my uterus and fallopian tubes open and structurally suitable?
Imaging or procedures such as hysterosalpingography may help assess the uterine cavity and whether the fallopian tubes appear open. Ask what your imaging showed, whether a finding is definite or uncertain, and whether it could affect conception, miscarriage risk, or treatment choice. If a possible polyp, fibroid, adhesion, or tubal issue was identified, ask whether it needs confirmation or treatment before proceeding.
What does the semen analysis show, and should it be repeated?
A semen analysis typically assesses factors such as sperm concentration, movement, and shape. Results can vary between samples, and interpretation should consider the laboratory’s methods and the clinical context. Ask whether the result warrants a repeat sample, a reproductive-urology consultation, or additional testing. The American Urological Association and ASRM recommend evaluating both partners in parallel when appropriate, rather than postponing male-factor assessment until all testing on the female partner is complete.
Do we need any additional tests—or would they not change management?
More testing is not always more useful. Ask what decision a proposed test would inform, how accurate it is, and whether its result would change your options. This question is particularly important for tests marketed as broad fertility screens: ASRM advises against routine use of several tests without a specific clinical indication. A clinician should explain the expected benefit, limitations, cost, and possible downsides before ordering further investigations.
Questions about treatment options, timing, risks, and cost
After reviewing the findings, ask your doctor to turn them into a practical plan. The appropriate path may include trying without treatment for a defined period, addressing a medical issue, using medication or insemination, considering surgery in selected cases, or discussing in vitro fertilization (IVF). Recommendations depend on the diagnosis, age, preferences, and other factors—not solely on test results.
What are our options, and why do you recommend this one?
Ask your doctor to compare reasonable options, including no immediate treatment if appropriate. For each option, discuss the goal, expected process, likely benefits, limitations, and alternatives. Ask for success estimates that match your age, diagnosis, and treatment type, and clarify whether the figure refers to pregnancy, clinical pregnancy, or live birth. National outcomes reported by the CDC’s Assisted Reproductive Technology Surveillance System can provide context, but national averages cannot predict an individual result.
How urgent is treatment in my circumstances?
Ask how age, time trying, diagnosis, and ovarian-reserve findings affect the recommended timeline. Request a specific date or milestone for reassessment if you plan to wait or try a less intensive approach. Avoid interpreting a single reserve result as a precise countdown: ASRM notes that ovarian-reserve tests are not reliable stand-alone measures of natural fertility or future reproductive potential.
What are the risks, side effects, and chance of multiple pregnancy?
Treatment risks vary by medication and procedure. Ask about side effects, monitoring, complications, and whether treatment could increase the chance of twins or higher-order pregnancy. For IVF, discuss how the clinic approaches embryo transfer and the balance between pregnancy chances and multiple-pregnancy risks. Ask which symptoms require urgent medical attention and whom to contact after hours.
What will treatment cost, and what is covered?
Request an itemized estimate that includes consultations, medications, procedures, laboratory services, storage, and possible repeat cycles. Ask your insurer and clinic to clarify coverage, authorization requirements, medication benefits, and payment deadlines. The financial plan matters because treatment may involve costs beyond the headline price, and coverage differs by plan and location.
Questions about next steps, communication, and support
A good follow-up visit ends with a shared understanding of what happens next. Before leaving, make sure you know who coordinates care, when results or referrals are expected, and how to reach the clinic with questions.
What should we do now, and when will we review progress?
Ask for a written plan with the next action, responsible person, and target date. Confirm whether you should continue trying to conceive, change medication, schedule a procedure, or arrange another consultation. If a test or referral is pending, ask how and when the clinic will communicate the result and what to do if you do not hear back.
Should we seek a second opinion or see a specialist?
A referral may be useful when results suggest a complex uterine, tubal, hormonal, or male-factor issue, or when you want another perspective before treatment. Ask whether a reproductive endocrinologist, reproductive urologist, genetic counselor, or another specialist should be involved. You can also request copies of test reports and medical records to support continuity of care.
What emotional or practical support is available?
Testing and treatment can bring uncertainty, stress, and difficult decisions for individuals and couples. Ask whether the clinic offers counseling, support groups, or referrals to mental-health professionals familiar with fertility care. Consider bringing a trusted support person to the appointment, taking notes, and sharing questions in advance so the discussion is easier to follow.
Conclusion: leave with a clear fertility-care plan
After fertility testing, focus on what the findings mean, how reliable and limited each test is, and whether results point to ovulation, ovarian reserve, reproductive anatomy, sperm, or more than one factor. Then ask how the findings shape treatment choices, timing, risks, costs, and follow-up. Bring a written question list, request explanations in everyday language, and ask for a copy of your plan. A thoughtful conversation helps turn test results into informed decisions while recognizing that no single result can determine an individual outcome.
Sources: Centers for Disease Control and Prevention, Infertility, https://www.cdc.gov/reproductive-health/infertility/; American Society for Reproductive Medicine, Fertility evaluation of infertile women: a committee opinion, https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2021/; American Society for Reproductive Medicine, Testing and interpreting measures of ovarian reserve: a committee opinion, https://www.asrm.org/practice-guidance/practice-committee-documents/testing-and-interpreting-measures-of-ovarian-reserve-a-committee-opinion-2020/; World Health Organization, Infertility, https://www.who.int/news-room/fact-sheets/detail/infertility; American Urological Association and American Society for Reproductive Medicine, Diagnosis and treatment of infertility in men: AUA/ASRM guideline, https://www.auanet.org/guidelines-and-quality/guidelines/male-infertility; Centers for Disease Control and Prevention, Assisted Reproductive Technology (ART), https://www.cdc.gov/art/.